Dmitriy Genkin
Vorsitzender bei PHARMSYNTHEZ
Vermögen: 267 010 $ am 31.05.2024
Aktive Positionen von Dmitriy Genkin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMSYNTHEZ | Vorsitzender | 01.01.2005 | - |
XENETIC BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - | - |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Direktor/Vorstandsmitglied | - | - |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Direktor/Vorstandsmitglied | 01.01.2013 | - |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | 01.01.2003 | - |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Direktor/Vorstandsmitglied | 01.01.2007 | - |
FDS Pharma Associates Ltd. | Direktor/Vorstandsmitglied | 17.11.2010 | - |
Corporate Officer/Principal | 17.11.2010 | - | |
░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Karriereverlauf von Dmitriy Genkin
Ehemalige bekannte Positionen von Dmitriy Genkin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Dmitriy Genkin
Mechnikov St Petersburg State Medical Academy | Undergraduate Degree |
The School of Pharmacy University of London | Graduate Degree |
Statistik
International
Russland | 6 |
Vereinigtes Königreich | 5 |
Estland | 3 |
Operativ
Director/Board Member | 12 |
Corporate Officer/Principal | 2 |
Founder | 1 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PHARMSYNTHEZ | Health Technology |
HUMAN STEM CELLS INSTITUTE | Health Services |
XENETIC BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
FDS Pharma Associates Ltd. | |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Retail Trade |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Health Technology |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Health Technology |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
CLS THERAPEUTICS, INC. | |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Health Technology |
- Börse
- Insiders
- Dmitriy Genkin
- Erfahrung